Início › Doença Hepática Esteatótica › Texas › San Antonio
Ensaios clínicos de Doença Hepática Esteatótica em San Antonio, TX
17 estudos para Doença Hepática Esteatótica estão buscando participantes em locais em San Antonio e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecrutandoFase 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecrutandoFase 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- e mais 2
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecrutandoFase 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecrutandoFase 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
RecrutandoFase 2
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RecrutandoFase 2
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecrutandoFase 3
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- e mais 1
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecrutandoFase 3
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- e mais 2
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecrutandoFase 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecrutandoFase 2
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
RecrutandoFase 4
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RecrutandoFase 2
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecrutandoFase 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RecrutandoFase 2
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
RecrutandoFase 1
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
RecrutandoFase 1
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RecrutandoEstudo observacional
- Endeavor Clinical Trials, San Antonio
Ensaios de Doença Hepática Esteatótica em outras cidades
- New York City, NY16 estudos
- Miami, FL16 estudos
- San Diego, CA14 estudos
- Austin, TX13 estudos
- Houston, TX13 estudos
- Richmond, VA12 estudos
- Tucson, AZ10 estudos
- Chandler, AZ10 estudos
- Hialeah, FL9 estudos
- Orlando, FL9 estudos
- St. Louis, MO9 estudos
- Dallas, TX9 estudos
Outros estudos em San Antonio
- Câncer de Pulmão de Não Pequenas Células59 estudos
- Câncer de Mama47 estudos
- Câncer Colorretal46 estudos
- Câncer Metastático44 estudos
- Câncer (todos os tipos)41 estudos
- Obesidade40 estudos
- Diabetes tipo 237 estudos
- Sobrepeso34 estudos
- Câncer de Ovário31 estudos
- Câncer de Pâncreas31 estudos
- Câncer de Próstata28 estudos
- Câncer Endometrial27 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.